On the other hand, a GLP-1 receptor agonist may be a better initial strategy in a type 2 diabetes patient with (or at very high risk for) atherosclerotic cardiovascular disease (ASCVD), especially if there is concomitant obesitycontributing to the disease process. Limited Comparisons of These Two Newer Drug Classes Real-world evidence comparing these two therapeutic classes based on CV outcomes is limited, Poonawalla said at the start of her presentation, and relative treatment persistence, utilization, and cost data are even less well studied
the energy centre of the cell
Exercise improves circulation, oxygenates your tissues, and enhances the work of the lymphatic system through muscle contractions
Data is limited, but metabolic health directly links to male fertility
Whether you have questions, need dose adjustments, or want to celebrate progress, your care team is just a message away